Skip to main content

Advertisement

Log in

Weight loss in Parkinson’s disease

  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Weight loss is frequent in patients with Parkinson’s disease (PD). Reduced energy intake and/or increased energy expenditure have been postulated as the cause. Dysphagia, anorexia, and gastrointestinal dysfunction may be possible causes of reduced energy intake; whereas, rigidity, tremor, and levodopa-induced dyskinesia may increase energy expenditure. Levodopa may enhance glucose metabolism resulting in enhanced energy expenditure. Depression, anti-parkinsonian drugs, and medical complications such as pneumonia and malignancies also may facilitate weight loss in PD. Combinations of various degrees of these factors, especially in advanced PD, may produce weight loss. Such weight loss is associated with malnutrition which may precipitate infection and decubitis; accelerate motor, behavioral, and autonomic impairment; consequently spoiling one’s quality of life. Attention must be paid as well to motor symptoms to prevent or reverse weight loss in PD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abbott RA, Cox M, Markus H, Tomkins A (1992) Diet, body size and micronutrient status in Parkinson’s disease. Eur J Clin Nutr 46:879–884

    PubMed  CAS  Google Scholar 

  2. Beyer PL, Palarino MY, Michalek D, Busenbark K, Koller WC (1995) Weight change and body composition in patients with Parkinson’s disease. J Am Diet Assoc 95:979–983

    Article  PubMed  CAS  Google Scholar 

  3. Broussolle E, Borson F, Gonzalez de Suso JM, Chayvialle JA, Beylot M, Chazot C (1991) Augmentation de la depense energetique au cours de la maladie de Parkinson. Rev Neurol 147:46–51

    PubMed  CAS  Google Scholar 

  4. Campbell AJ, Spears GF, Brown JS, Busby WJ, Borrie MJ (1990) Anthropometric measurements as predictors of mortality in a community population aged 70 years and over. Age Ageing 19:131–135

    PubMed  CAS  Google Scholar 

  5. Chen H, Zhang SM, Hernan MA, Willett WC, Ascherio A (2003) Weight loss in Parkinson’s disease. Ann Neurol 53:676–679

    Article  PubMed  Google Scholar 

  6. Davies KN, King D, Davies H (1994) A study of the nutritional status of elderly patients with Parkinson’s disease. Age Ageing 23:142–145

    PubMed  CAS  Google Scholar 

  7. Durrieu G, Llau ME, Rascol O, Senard JM, Rascol A, Montastruc JL (1992) Parkinson’s disease and weight loss: a study with anthropometric and nutritional assessment. Clin Auton Res 2:153–157

    Article  PubMed  CAS  Google Scholar 

  8. Edwards LL, Pfeiffer RF, Quigley EMM, Hofman R, Balluff M (1991) Gastrointestinal symptoms in Parkinson’s disease. Mov Disord 6:151–156

    Article  PubMed  CAS  Google Scholar 

  9. Evidente VGH, Caviness JN, Adler CH, Gwinn-Hardy KA, Pratley RE (2001) Serum leptin concentrations and satiety in Parkinson’s disease patients with and without weight loss. Mov Disord 16:924–927

    Article  PubMed  CAS  Google Scholar 

  10. Gasparini M, Spinnler H (1975) Fatting of parkinsonians: a hypothalamic side effect of L-dopa? Med J Aust 2:617

    PubMed  CAS  Google Scholar 

  11. Jankovic J, Wooten M, Van der Linden C, Hansson B (1992) Low body weight in Parkinson’s disease. Southern Med J 85:351–354

    Article  CAS  PubMed  Google Scholar 

  12. Kytömäki O, Nousiainen R, Pekkarinen A, Rinne UK, Viljanen M (1973) Plasma growth hormone and insulin response to levodopa and amantadine. J Neural Transm 34:145–151

    Article  PubMed  Google Scholar 

  13. Levi S, Cox M, Lugon M, Hodkinson M, Tomkins A (1990) Increased energy expenditure in Parkinson’s disease. Br Med J 301:1256–1257

    Article  CAS  Google Scholar 

  14. Markus HS, Cox M, Tomkins AM (1992) Raised resting energy expenditure in Parkinson’s disease and its relationship to muscle rigidity. Clin Sci 83:199–204

    PubMed  CAS  Google Scholar 

  15. Markus HS, Tomkins AM, Stern GM (1993) Increased prevalence of under nutrition in Parkinson’s disease and its relationship to clinical disease parameters. J Neural Transm (P-D Sect) 5:117–125

    Article  CAS  Google Scholar 

  16. Moroo I, Yamada T, Hirayama K (1994) Body weight loss in patients with Parkinson’s disease. Neurological Med 41:65–67 (in Japanese)

    Google Scholar 

  17. Nirenberg MJ, Water C (2006) Compulsive eating and weight gain related to dopamine agonist use. Mov Disord 21?:524–529

    Article  PubMed  Google Scholar 

  18. Nozaki S, Saito T, Matsumura T, Miyai I, Kang J (1999) Relationship between weight loss and dysphasia in patients with Parkinson’s disease. Clinical Neurol 39:1010–1014 (in Japanese)

    CAS  Google Scholar 

  19. Ondo WG, Ben-Aire L, Jankovic J, Lai E, Contant C, Grossman R (2000) Weight gain following unilateral pallidotomy in Parkinson’s disease. Acta Neurol Scand 101:79–84

    Article  PubMed  CAS  Google Scholar 

  20. Parkinson J (1817) An essay on the shaking palsy. Whillingham and Bowland, London

  21. Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson’s disease. Lancet Neurology 2:107–116

    Article  PubMed  Google Scholar 

  22. Rosati G, Maioli M, Aiello I, Farris A, Agnetti V (1976) Effects of long-term L-dopa therapy on carbohydrate metabolism in patients with Parkinson’s disease. Eur Neurol 14:229–239

    PubMed  CAS  Google Scholar 

  23. Sandyk R (1993) The relationship between diabetes mellitus and Parkinson’s disease. Int J Neurosci 69:125–130

    Article  PubMed  CAS  Google Scholar 

  24. Sirtori CR, Bolme P, Azarnoff DL (1972) Metabolic response to acute and chronic L-dopa administration in patients with parkinsonism. New Engl J Med 287:729–733

    Article  PubMed  CAS  Google Scholar 

  25. Stevenson JAF, Montemurro DF (1963) Loss of weight and metabolic rate of rats with lesions in the medial and lateral hypothalamus. Nature 198:92

    Article  PubMed  CAS  Google Scholar 

  26. Toth MJ, Fishman PS, Poehlman ET (1997) Free-living daily energy expenditure in patients with Parkinson’s disease. Neurology 48:88–91

    PubMed  CAS  Google Scholar 

  27. Tuite PJ, Maxwell RE, Ikramuddin S, Kotz CM, Billington CJ, Thielen SD (2005) Weight and body mass index in Parkinson’’s disease patients after deep brain stimulation surgery. Parkinsonism Relat Disord 11:247–252

    Article  PubMed  Google Scholar 

  28. Uc EY, Struck LK, Rodnitzky RL, Zimmerman B, Dobson J, Evans WJ (2006) Predictors of weight loss in Parkinson’s disease. Mov Disord 21:930–936

    Article  PubMed  Google Scholar 

  29. Vardi J, Oberman Z, Rabey I, Streifler M, Ayalon D, Herzberg M (1976) Weight loss in patients treated long-term with levodopa. J Neurol Sci 30:33–40

    Article  PubMed  CAS  Google Scholar 

  30. Wodak J, Gilligan BS, Veale JL, Dowty BJ (1972) Review of 12 months’ treatment with L-dopa in Parkinson’s disease, with remarks on unusual side effects. Med J Aust 2:1277–1282

    PubMed  CAS  Google Scholar 

  31. Wszolek ZK, Markopoulou K (1998) Olfactory dysfunction in Parkinson’s disease. Clin Neurosci 5:94–101

    Article  PubMed  CAS  Google Scholar 

  32. Yapa RSS, Playfer JR, Lye M (1989) Anthropometric and nutritional assessment of elderly patients with Parkinson’s disease. J Clin Exp Gerontol 11:155–164

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kenichi Kashihara.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kashihara, K. Weight loss in Parkinson’s disease. J Neurol 253 (Suppl 7), vii38–vii41 (2006). https://doi.org/10.1007/s00415-006-7009-0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-006-7009-0

Key words

Navigation